awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50556522-27523EE8-29B7-4FA9-81BF-AA4E2C96FDB7
Q50556522-27523EE8-29B7-4FA9-81BF-AA4E2C96FDB7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50556522-27523EE8-29B7-4FA9-81BF-AA4E2C96FDB7
An open, prospective trial investigating the pharmacokinetics and safety, and the tolerability of escalating infusion rates of a 10% human normal immunoglobulin for intravenous infusion (IVIg), BT090, in patients with primary immunodeficiency diseas
P2860
Q50556522-27523EE8-29B7-4FA9-81BF-AA4E2C96FDB7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50556522-27523EE8-29B7-4FA9-81BF-AA4E2C96FDB7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7e00b2ccd756a9f315b675417626b77ed2e3008a
P2860
Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiency.